Urinary Tract

  • Peter Spieler
  • Matthias Rössle
Part of the Essentials of Diagnostic Pathology book series (ESSENTPATH)

Abstract

Practical relevance of ancillary studies such as immunocytochemistry, cytometric DNA quantitation, and fluorescence in situ hybridization is highlighted in a first section.

The ‘benign section’ particularly deals with dilemmas in diagnostic workup of degenerative and reactive urothelial atypia. Furthermore, cell changes due to polyomavirus infection are described in detail.

Cytology of the following disorders in exfoliative samples from bladder, ureter and renal pelvis is broadly discussed in a third section: (1) Prostatic ductal adenocarcinoma involving urethra, (2) precancerous urothelial lesions, (3) papillary transitional cell carcinomas, (4) solid transitional cell carcinomas, (5) other primary urinary tract cancers, and (6) non-urothelial carcinomas potentially causing diagnostic confusion in the case of invading the urinary collecting system.

Cytodiagnostic algorithms of benign, precancerous and malignant lesions and their respective differential diagnoses are additionally presented in synoptic setups.

Keywords

Bladder Cancer Transitional Cell Transitional Cell Carcinoma Urothelial Carcinoma Urothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

Further Reading (Sect. 13.1)

  1. 1.
    Alishahi S, Byrne D, Goodman CM, Baxby K. Haematuria investigation based on standard protocol: emphasis on the diagnosis of urological malignancy. J R Coll Surg Edinb 2002;47:422-427.PubMedGoogle Scholar
  2. 2.
    Amberson JB, Laino JP. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma. J Urol 1993;149:42-45.PubMedGoogle Scholar
  3. 3.
    Baak JPA, Bol MGW, van Diermen B, et al. CNA cytometry features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality. Urology 2003;61:1266-1272.PubMedCrossRefGoogle Scholar
  4. 4.
    Bertino B, Knape WA, Pytlinska M et al. A comparative study of DNA content as measured by flow cytometry and image analysis in 1864 specimens. Anal Cell Pathol 1994;6:377-394.PubMedGoogle Scholar
  5. 5.
    Bian Y, Ehya H, Bagley DH. Cytologic diagnosis of upper urinary tract neoplasms by ureteroscopic sampling. Acta Cytol 1995;39:733-740.PubMedGoogle Scholar
  6. 6.
    Bibbo M, Gill WB, Harris MJ, et al. Retrograde brushing as a diagnostic procedure of ureteral, renal pelvic and renal calyceal lesions. A preliminary report. Acta Cytol 1974;18:137-141.PubMedGoogle Scholar
  7. 7.
    Biesterfeld S, Borchers H, Jellouschek H, et al. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry. Anticancer Res 2005;25:3243-3249.PubMedGoogle Scholar
  8. 8.
    Bol MG, Baak Jp, Diermen B, et al. Correlation of grade of urothelial cell carcinomas and DNA histogram features assessed by flow cytometry and automated image cytometry. Anal Cell Pathol 2003;25:147-153.PubMedGoogle Scholar
  9. 9.
    Boudry C, Herlin P, Coster M, Chermant JL. Influence of sample size on image cytometry of DNAploidy measurements.Anal Quant Cytol Histol 1999;21:209-215.PubMedGoogle Scholar
  10. 10.
    Bubendorf L, Grilli B, Sauter G, et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 2001;116:79-86.PubMedCrossRefGoogle Scholar
  11. 11.
    Cai T, Margallo E, Nesi G, et al. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Oncol Rep 2006;15:213-219.PubMedGoogle Scholar
  12. 12.
    Caraway NP, Khanna A, Payne L, et al. Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions. Cancer(Cancer Cytopathol) 2007;111:323-329.Google Scholar
  13. 13.
    Chahai R, Gogoi NK, Sundaram SK. Is it necessary to perform urine cytology in screening patients with haematuria? Eur Urol 2001;39:283-286.CrossRefGoogle Scholar
  14. 14.
    Cianciulli AM, Bovani R, Leonardo C, et al. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: prognostic implications. Eur J Histochem 2001;45:65-71.PubMedGoogle Scholar
  15. 15.
    Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl. 2000;205:105-115.PubMedCrossRefGoogle Scholar
  16. 16.
    Dalquen P, Kleiber B, Grilli B, et al. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine. Cancer 2002;96:374-379.PubMedCrossRefGoogle Scholar
  17. 17.
    Daniely M, Rona R, Kaplan T, et al. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Cancer(Cancer Cytopathol) 2007;111:517-524.Google Scholar
  18. 18.
    Degtyar P, Neulander E, Zirkin H, et al. fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Urology 2004;63:398-401.PubMedCrossRefGoogle Scholar
  19. 19.
    deVere White RW, Deitch AD. Evaluation of DNA flow cytometry as a screening test for bladder cancer. J Cell Biochem Suppl. 1992;161:80-84CrossRefGoogle Scholar
  20. 20.
    Dodd LG, Johnston WW, Robertson CN, et al. Endoscopic brush cytology of the upper urinary tract. Evaluation of its efficacy and potential limitations in diagnosis. Acta Cytol 1997;41:377-384.PubMedCrossRefGoogle Scholar
  21. 21.
    Eissa S, Kassim S, El-Ahmady O. Detection of bladder tumors: role of cytology, morphology-based assays, biochemical and molecular markers. Curr Opin Obstet Gynecol 2003;15:395-403.PubMedCrossRefGoogle Scholar
  22. 22.
    Goulandris N, Karakitsos P, Georgoulakis J, et al. Deoxyribonucleic acid measurements in transitional cell carcinomas: comparison of flow and image cytometry techniques. J Urol 1996;156:958-960.PubMedCrossRefGoogle Scholar
  23. 23.
    Grossman Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Urol Oncol 2008;26:332.Google Scholar
  24. 24.
    Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol 2005;12:709-716.PubMedCrossRefGoogle Scholar
  25. 25.
    Halling KC, King W, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000;164:1768-1775.PubMedCrossRefGoogle Scholar
  26. 26.
    Hammerich KH, Gustavo EA, Wheeler TM. Application of immunohistochemistry to the genitourinary system (prostate, urinary bladder, testis, and kidney). Arch Pathol Lab Med 2008;132:432-440.PubMedGoogle Scholar
  27. 27.
    Haroske G, Baak JP, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 2001;23:89-95.PubMedGoogle Scholar
  28. 28.
    Höglund M. On the origin of syn- and metachronous urothelial carcinomas. Eur Urol 2007;51:1185-1193.PubMedCrossRefGoogle Scholar
  29. 29.
    Ide H, Kikuchi E, Shinoda K, et al. Carcinoma in situ developing in an ileal neobladder. Urology 2007;69:576.e9-11. Raica Rom J J Morphol Embryol 1992Google Scholar
  30. 30.
    Jacobs R. A review of the effectiveness of urinary cytology as a screening technique for occupational bladder cancer. J Soc Occup Med 1987;37:24-26.PubMedCrossRefGoogle Scholar
  31. 31.
    Jones JS. DNA-based molecular cytology for bladder cancer surveillance. Urology 2006;67(3 Suppl 1):35-45.PubMedCrossRefGoogle Scholar
  32. 32.
    Kälble T. Etiopathology, risk factors, environmental influences and epidemiology of bladder cancer. Urologe A 2001;40:447-450.PubMedCrossRefGoogle Scholar
  33. 33.
    Kern W. Screening tests for bladder cancer. In: Screening for cancer. ed: Miller AB. Orlando Academic Press, pp 121-140, 1985.Google Scholar
  34. 34.
    Kline MJ, Wilkinson EJ, Askeland R, et al. DNA tetraploidy in Feulgen-stained bladder washings assessed by image cytometry. Anal Quant Cytol Histol 1995;17:129-134.PubMedGoogle Scholar
  35. 35.
    Knapik JA, Murphy WM. Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion. Cancer 2003;99:352-356.PubMedCrossRefGoogle Scholar
  36. 36.
    Koss LG. Urinary cytology: the subjective diagnostic clues and their evaluation by computer. Anal Quant Cytol Histol 1979;1:202-206.Google Scholar
  37. 37.
    Koss LG, Deitch D, Ramanathan R, Sherman AB. Diagnostic value of cytology of voided urine. Acta Cytol 1985;29:810-816.PubMedGoogle Scholar
  38. 38.
    Krause FS, Feil G, Zumbrägel A, Bichler KH. Molecular genetic methods in the diagnosis of invasive bladder cancer. Anticancer Res 2000;20:5015-5021.PubMedGoogle Scholar
  39. 39.
    Krause FS, Feil G, Bichler KH, et al. Clinical aspects for the use of DNA image cytometry in detection of bladder cancer: a valuable tool? DNA Cell Biol 2003;22:721-725.PubMedCrossRefGoogle Scholar
  40. 40.
    Lin DW, Herr HW, Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol 2003;169:961-963.PubMedCrossRefGoogle Scholar
  41. 41.
    Mainguené C, Choquenet C, Deplano C, et al. DNA ploidy by image cytometry in urothelial carcinomas. Comparison of touch imprints and paraffin-embedded biopsies from 31 patients. Anal Quant Cytol Histol 1997;19:437-442.PubMedGoogle Scholar
  42. 42.
    Palmeira CA, Oliveira PA, Seixas F, et al. DNA image cytometry in bladder cancer: state of the art. Anticancer Research 2008;28:443-450.PubMedGoogle Scholar
  43. 43.
    Planz B, Synek C, Robben J, et al. Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer. Urology 2000;56:782-786.PubMedCrossRefGoogle Scholar
  44. 44.
    Raica M, Ioiart I Urethral and neobladder cytologic survey in patients with total cystectomy. Rom J Morphol Embryol 1992;38:29-34.PubMedGoogle Scholar
  45. 45.
    Ross JS, Cohen MB. Biomarkers for the detection of bladder cancer. Adv Anat Pathol 2001;8:37-45.PubMedCrossRefGoogle Scholar
  46. 46.
    Sack MJ, Artymyshyn RL, Tomaszewski, Gupta PK. Diagnostic value of bladder wash cytology, with special reference to low grade urothelial neoplasms. Acta Cytol 1995;39:187-194.PubMedGoogle Scholar
  47. 47.
    Sauter G, Gasser TC, Moch H, et al. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res 1997;25 Suppl 1:S37-43.PubMedCrossRefGoogle Scholar
  48. 48.
    Schapers RF, Ploem-Zaaijer JJ, Pauwels RP, et al. Image cytometric DNA analysis in transitional cell carcinoma of the bladder. Cancer 1993;72:182-189.PubMedCrossRefGoogle Scholar
  49. 49.
    Schwarz S, Rechenmacher M, Filbeck T, et al. Value of muticolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions. J Clin Pathol 2008;61:272-277.PubMedCrossRefGoogle Scholar
  50. 50.
    Seigneurin D, Rambeaud JJ, Bosio C, Louis J. DNA image cytometry of bladder tumors: comparison of washings and tumor imprints from 61 patients. Anal Cell Pathol 1993;5:39-48.PubMedGoogle Scholar
  51. 51.
    Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003;169:2101-2105.PubMedCrossRefGoogle Scholar
  52. 52.
    Stein JP, Clark P, Miranda G, et al. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol 2005;173:1163-1168.PubMedCrossRefGoogle Scholar
  53. 53.
    Steiner H, Bergmeister M, Verdorfer I, et al. Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int 2008;102:291-296.PubMedCrossRefGoogle Scholar
  54. 54.
    Stöckle M, Steinbach F, Voges H, Hohenfellner R. Image analysis DNA cytometry of bladder cancer. Recent Results Cancer Res 1993;126:151-163.PubMedCrossRefGoogle Scholar
  55. 55.
    Tachibana M, Miyakawa A, Miyakawa M, et al. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study. Cancer Detect Prev 1999;23:155-162.PubMedCrossRefGoogle Scholar
  56. 56.
    van der Poel HG, Boon ME, van Stratum P, et al. Conventional bladder wash cytology performed by four experts versus quantitative image analysis. Mod Pathol 1997;10:976-982.PubMedGoogle Scholar
  57. 57.
    Veeramachaneni R, Nordberg ML, Shi R, et al. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 2003;28:301-307.PubMedCrossRefGoogle Scholar
  58. 58.
    Viswanath S, Zelhof B, Ho E, et al. Is routine urine cytology useful in the haematuria clinic? Ann R Coll Surg Engl 2008;90:153-155.PubMedCrossRefGoogle Scholar
  59. 59.
    Zaher A, Sheridan T. Tumor markers in the detection of recurrent transitional carcinoma of the bladder: a brief review. Acta Cytol 2001;45:575-581.PubMedCrossRefGoogle Scholar

Further Reading (Sect. 13.2)

  1. 1.
    Akhter N, Sohail I, Shah S, et al. Vesical endometriosis. J Coll Physicians Surg Pak 2007;17:702-703.PubMedGoogle Scholar
  2. 2.
    Ballesteros Sampol JJ. Urogenital malakoplakia. Report of 4 cases and review of the literature. Arch Esp Urol 2001;54:768-776.PubMedGoogle Scholar
  3. 3.
    Boldorini R, Brustia M, Veggiani C, et al. Periodic assessment of urine and serum by cytology and molecular biology as a diagnostic tool for BK virus nephropathy in renal transplant patients. Acta Cytol 2005;49:235-243.PubMedCrossRefGoogle Scholar
  4. 4.
    Borda A, Petrucci MD, Berger N. Miscellaneous benign lesions of the bladder and the urinary tract. Ann Pathol 2004;24:18-30.PubMedCrossRefGoogle Scholar
  5. 5.
    Chen SS, Hsu YS, Chen KK, Chang LS. Urinary bladder endometriosis: a report of two cases. Zhonghua Yi Xue Za Zhi(Taipei) 1996;58:66-69.Google Scholar
  6. 6.
    Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl. 2000;205:105-115.PubMedCrossRefGoogle Scholar
  7. 7.
    de Ruiter F, Beyer-Boon ME, de Voogt HJ. The effect of calculi on transitional epithelium. A clinical and cytological study. Urol Res 1975;3:67-72.PubMedCrossRefGoogle Scholar
  8. 8.
    Goel R, Kadam G, Devra A, et al. Xanthogranulomatous cystitis. Int Urol Nephrol 2007;39:477-478.PubMedCrossRefGoogle Scholar
  9. 8.
    A. Guan H, Rosenthal DL, Erozan YS. Mullerianosis of the urinary bladder: report of a case with diagnosis suggested in urine cytology and review of literature. Diagn Cytopathol 2011 Apr 28, [Epub ahead of print].Google Scholar
  10. 9.
    Hatzinger M, Vöge D, Häfele J et al. Manifestation of malakoplakia in a urethral diverticulum in a female patient. Aktuelle Urol 2008;39:68-70.PubMedCrossRefGoogle Scholar
  11. 10.
    Highman W, Wilson E. Urine cytology in patients with calculi. J Clin Pathol 1982;35:350-356.PubMedCrossRefGoogle Scholar
  12. 11.
    Ho KL. Morphogenesis of Michaelis-Gutmann bodies in cerebral malakoplakia. An ultrastructural study. Arch Pathol Lab Med 1989;113:874-879.PubMedGoogle Scholar
  13. 12.
    Jimenez-Heffernan JA, Sanchez-Piedra D, Bernaldo de Quiros L, Martinez V. Endosalpingiosis (müllerianosis) of the bladder: a potential source of error in urinary cytology. Cytopathology 2000;11:348-353.PubMedCrossRefGoogle Scholar
  14. 13.
    Jorge AA, Lucon AM, Bloise W, Mendoca BB. Pheochromocytoma of the urinary bladder, report of a case and review of the literature. Rev Hosp Clin Fac Med Sao Paulo 1997;52:28-31.PubMedGoogle Scholar
  15. 14.
    Kannan V, Gupta D. Calculus artifact. A challenge in urinary cytology. Acta Cytol 1999;43:794-800.PubMedCrossRefGoogle Scholar
  16. 15.
    Kapila K, Nampoory MR, Johny KV, et al. Role of urinary cytology in detecting human polyoma BK virus in kidney transplant recipients. A preliminary report. Med Princ Pract 2007;16:237-239.PubMedCrossRefGoogle Scholar
  17. 16.
    Koren J, Mensikova J, Mukensnabl P, Zamecnik M. Mullerianosis of the urinary bladder: report of a case with suggested metaplastic origin. Virchows Arch 2006;449:268-271.PubMedCrossRefGoogle Scholar
  18. 17.
    Koss LG. Diagnostic cytology and its histopathologic bases. Fifth ed. Lippincott Williams & Wilkins, Philadelphia, 2006.Google Scholar
  19. 18.
    Mazzuchelli R, Barbisan F, Tarquini LM, et al. Urothelial changes induced by therapeutic procedures for bladder cancer. A review. Anal Quant Cytol Histol 2005;27:27-34.Google Scholar
  20. 19.
    Medeiros M, Alberu J, Garcia GR, et al. Polyoma virus in transplant recipients. Nefrologia 2008;28:203-211.PubMedGoogle Scholar
  21. 20.
    Mogorovich A, Giannarini G, De Maria M, et al. Granular cell tumor of the urinary bladder: a case report and review of the literature. Arch Ital Urol Androl 2007;79:43-44.PubMedGoogle Scholar
  22. 21.
    Ng KF, Chen TC, Hsueh S. Malakoplakia of urinary tract: report of two cases emphasizing the histologic spectrum and the morphogenesis of Michaelis-Gutmann bodies. Changgeng Yi Xue Za Zhi 1996;19:55-61.PubMedGoogle Scholar
  23. 22.
    Nikolaeva D, BS, Ali SZ. Significance of urothelial atypia in exfoliative cytology of upper urinary tract lesions. Cancer (Cancer Cytopathol) Suppl . 2007;111/Issue 5:424-425.Google Scholar
  24. 23.
    Pastor Navarro H, Donate Moreno MJ, Gimenez Bachs JM, et al. Bladder endometriosis. A report of two cases and bibliographic review, with special focus on Spanish articles. Arch Esp Urol 2006;59:111-122PubMedCrossRefGoogle Scholar
  25. 24.
    Piscioli F, Pusiol T, Polla E, et al. Urinary cytology of tuberculosis of the bladder. Acta Cytol 1985;29:125-131.PubMedGoogle Scholar
  26. 25.
    Raica M, Ioiart I. Urethral and neobladder cytology survey in patients with total cystectomy. Rom J Morphol Embryol 1992;XXX-VIII:29-34.Google Scholar
  27. 26.
    Remick DG, Kumar NB. Benign polyps with prostatic-type epithelium of the urethra and the urinary bladder. Am J Surg Pathol 1984;8:833-839.PubMedCrossRefGoogle Scholar
  28. 27.
    Salvana EM, King CH. Schistosomiasis in travelers and immigrants. Curr Infect Dis Rep 2008;10:42-49.PubMedCrossRefGoogle Scholar
  29. 28.
    Scarlata F, Giordano S, Romano A, et al. Urinary schistosomiasis: remarks on a case. Infez Med 2005;13:259-264.PubMedGoogle Scholar
  30. 29.
    Schumann GB, Johnston JL, Weiss MA. Renal epithelial fragments in urine sediment. Acta Cytol 1981;25:147-152.PubMedGoogle Scholar
  31. 30.
    Singh HK, Bubendorf L, Mihatsch MJ, et al. Urine cytology findings of polyomavirus infections.Adv Exp Med Biol 2006;577:201-212.PubMedCrossRefGoogle Scholar
  32. 31.
    Tan LB, Chiang CP, Huang CH, Chian CH. Xanthogranulomatous cystitis: a case report and review of the literature. Int Urol Nephrol 1994;26:413-417.PubMedCrossRefGoogle Scholar
  33. 32.
    Waugh MS, Perfect JR, Dash RC. Schistosoma haematobium in urine: morphology with ThinPrep method. Diagn Cytopathol 2007;35:649-650.PubMedCrossRefGoogle Scholar
  34. 33.
    Whisnant RE, Bastacky SI, Ohori NP. Cytologic diagnosis of lowgrade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification. Diagn Cytopathol 2003;28:186-190.PubMedCrossRefGoogle Scholar
  35. 34.
    Young RH, Clement PB. Müllerianosis of the urinary bladder. Mod Pathol 1996;9:731-737.PubMedGoogle Scholar
  36. 35.
    Yuste RS, Frias C, Lopez A, et al. Diagnostic value of JC/BK virus antibody immunohistochemistry staining in urine samples from posttransplant immunosuppressed patients in relation to polyomavirus reactivation. Acta Cytol 2008;52:191-195.PubMedCrossRefGoogle Scholar
  37. 36.
    Zugor V, Schott GE. Endometriosis involving the ureter. The Erlangen experience exemplified by two case reports. Aktuelle Urol 2007;38:55-58.PubMedCrossRefGoogle Scholar

Further Reading (Sect. 13.3)

  1. 1.
    Ali SZ, Reuter VE, Zakowski MF. Small cell neuroendocrine carcinoma of the urinary bladder.Aclinicopathologic study with emphasis on cytologic features. Cancer. 1997;79:356-61.PubMedCrossRefGoogle Scholar
  2. 2.
    Asami H, Ito Y, Alda JS, et al. Small cell undifferentiated carcinoma of the urinary bladder: a cytodiagnostic case report of its variant type. Pathol Int 1997;47:876-882.PubMedCrossRefGoogle Scholar
  3. 3.
    Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 1999;23:1471-1479.PubMedCrossRefGoogle Scholar
  4. 4.
    Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004;101:957-962.PubMedCrossRefGoogle Scholar
  5. 5.
    Christensen WN, Steinberg G, Walsh PC, Epstein JI. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer 1991;67:2118-2124.PubMedCrossRefGoogle Scholar
  6. 6.
    Clark PE, Stein JP, Groshen SG, et al. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. J Urol 2004;172:1342-1347PubMedCrossRefGoogle Scholar
  7. 7.
    Crawford JM. The origins of bladder cancer. Lab Invest 2008;88:686-693.PubMedCrossRefGoogle Scholar
  8. 8.
    Curry JL, Wojcik EM. The effects of the current World Health Organization / International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Cancer(Cancer Cytopathol) 2002;96:140-145.Google Scholar
  9. 9.
    Doria MI Jr, Saint Martin G, Wang HH, et al. Cytologic features of clear cell carcinoma of the urethra and urinary bladder. Diagn Cytopathol 1996;14:150-154.PubMedCrossRefGoogle Scholar
  10. 10.
    Eble JN, Sauter G, Epstein JI, Sesterhenn IA. (Eds.): World Health Organization Classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs. IARC Press: Lyon 2004.Google Scholar
  11. 11.
    Epstein J, Amin MB, Reuter VR, Mostofi FK. Bladder consensus conference committee. The World Health Organization / International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-1448.PubMedCrossRefGoogle Scholar
  12. 12.
    Farrow GM, Utz DC,Rife CC. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer 1976;36:2495.Google Scholar
  13. 13.
    Garbar C, Mascaux C, Wespes E. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnosis. Cytopathology 2007;18:79-83.PubMedCrossRefGoogle Scholar
  14. 14.
    Gong Y, Caraway N, Stewart J, Staerkel G. Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings. Am J Clin Pathol 2006;126:302-309.PubMedCrossRefGoogle Scholar
  15. 15.
    Hayashi Y, Komada S, Maruyama, et al. Primary transitional cell carcinoma of the male urethra: report of a case. Hinyokika Kiyo 1987;33:428-432.PubMedGoogle Scholar
  16. 16.
    Jorge AA, Lucon AM, Bloise W, Mendoca BB. Pheochromocytoma of the urinary bladder, report of a case and review of the literature. Rev Hosp Clin Fac Med Sao Paulo 1997;52:28-31.PubMedGoogle Scholar
  17. 17.
    Kempton CL, Kurtin PJ, Inwards DJ, et al. Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol 1997;21:1324-1333.PubMedCrossRefGoogle Scholar
  18. 18.
    Knapik JA, Murphy WM. Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion. Cancer 2003;99:352-356.PubMedCrossRefGoogle Scholar
  19. 19.
    Koss LG, Tiamson EM, Robbins MD. Mapping of cancerous and precancerous bladder changes. JAMA 1974;227:281-285.PubMedCrossRefGoogle Scholar
  20. 20.
    Lagwinski N, Thomas A, Stephenson AJ, et al. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol 2007;31:1777-1787.PubMedCrossRefGoogle Scholar
  21. 21.
    Lin DW, Herr HW, Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol 2003;169:961-963.PubMedCrossRefGoogle Scholar
  22. 22.
    Maeda D, Fujii A, Yamaguchi K, et al. Sarcomatoid carcinoma with a predominant basaloid squamous carcinoma component: the first report of an unusual biphasic tumor of the ureter. Jpn J Clin Oncol 2007;37:878-883.PubMedCrossRefGoogle Scholar
  23. 23.
    Majewski T, Lee S, Jeong J, et al. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest 2008;88:694-721.PubMedCrossRefGoogle Scholar
  24. 24.
    Mikuz G. Non-urothelial tumors of the urinary tract. Verh Dtsch Ges Pathol 1993;77:180-198.PubMedGoogle Scholar
  25. 25.
    Murphy WM, Soloway MS: Urothelial dysplasia: A review. J Urol 1982;127:849-854.PubMedGoogle Scholar
  26. 26.
    Murphy WM, Soloway MS, Jukkola AF, et al. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-1565.PubMedCrossRefGoogle Scholar
  27. 27.
    Oliva E, Young RH. Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases. Mod Pathol 1996;9:513-520.PubMedGoogle Scholar
  28. 28.
    Ono Y, Matsumoto K, Kosaku N, et al. Transitional cell carcinoma in the fossa navicularis of the male urethra: a case report. Int J Urol 1998;5:294-295.PubMedCrossRefGoogle Scholar
  29. 29.
    Paner GP, McKenney JK, Epstein Ji, Amin MB. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol 2008;32:1022-1028.PubMedCrossRefGoogle Scholar
  30. 30.
    Pérez-Guillermo M, Acosta-Ortega J, Garcia-Solano J. Pitfalls and infrequent findings in fine-needle aspiration of the prostate gland. Diagn Cytopathol 2005;33:126-137.PubMedCrossRefGoogle Scholar
  31. 31.
    Peven DR, Hidvegi DF. Clear-cell adenocarcinoma of the female urethra. Acta Cytol 1985;29:142-146.PubMedGoogle Scholar
  32. 32.
    Proca DM, De Renne L, Marsh,Jr. WL, et al. Anaplastic large cell lymphoma in a human immunodeficiency virus-positive patient with cytologic findings in bladder wash. a case report. Acta Cytol 2008;52:83-86.PubMedCrossRefGoogle Scholar
  33. 33.
    Radhi JM. Urethral malignant melanoma closely mimicking urothelial carcinoma. J Clin Pathol 1997;250-252.PubMedCrossRefGoogle Scholar
  34. 34.
    Renshaw AA,, Nappi D, Weinberg DS. Cytology grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine. Acta Cytol 1996;40:676-682.PubMedCrossRefGoogle Scholar
  35. 35.
    Ro JY, Shen SS, Lee HI, et al. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Am J Surg Pathol 2008;32:752-757.PubMedCrossRefGoogle Scholar
  36. 36.
    Schwarz S, Rechenmacher M, Filbeck T, et al. Value of muticolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions. J Clin Pathol 2008;61:272-277.PubMedCrossRefGoogle Scholar
  37. 37.
    Stamatiou K, Alevizos A, Mariolis A, et al. Adenocarcinomas of the prostatic duct in necropsy material. Can J Urol 2007;14:3502-3506.PubMedGoogle Scholar
  38. 38.
    Stein JP, Clark P, Miranda G, et al. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 patients. J Urol 2005;173:1163-1168.PubMedCrossRefGoogle Scholar
  39. 39.
    Takahashi H, Hirano A, Nakano M, et al. Primary carcinoma of the female urethra. Hinyokika Kiyo 1989;35:1943-1945.PubMedGoogle Scholar
  40. 40.
    Takazawa R, Kawakami S, Yamamoto K, et al. A case of prostatic duct adenocarcinoma: its clinical significance in comparison with typical acinar adenocarcinoma. Hinyokika Kiyo 2008;54:243-247.PubMedGoogle Scholar
  41. 41.
    Tanaka T, Yoshimi N, Sawada K, et al. Ki-1-positive large cell anaplastic lymphoma diagnosed by urinary cytology. A case report. Acta Cytol 1993;37:520-524.PubMedGoogle Scholar
  42. 42.
    Vandersteen DP, Wiemerslage SJ, Cohen MB. Prostatic duct adenocarcinoma: a cytologic and histologic case report with review of the literature. Diagn Cytopathol 1997;17:480-483.PubMedCrossRefGoogle Scholar
  43. 43.
    Van der Kwast TH, Zlotta AR, Fleshner N, et al. Thirty-five years of noninvasive bladder carcinoma. Anal Quant Cytol Histol 2008;30:309-315.PubMedGoogle Scholar
  44. 44.
    Yoshizawa T, Kawata N, Sato K, et al. Primary malignant melanoma of the female urethra. Urology 2007;70:1222.e13-16.PubMedGoogle Scholar
  45. 45.
    Young RH, Scully RE. Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. Am J Surg Pathol. 1985;9:816-26.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Peter Spieler
    • 1
  • Matthias Rössle
    • 2
  1. 1.Institut für PathologieKantonsspital St. GallenSt. GallenSwitzerland
  2. 2.Institut für Klinische PathologieUniversitätsSpital ZürichZürichSwitzerland

Personalised recommendations